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Conclusion: apoC1 is a constitutive inhibitor of CETP in normolipidemic
humans, but it no longer operates in hyperlipidemic patients with CAD.
128 ARAP2-INDUCED CHANGES IN SPHINGOLIPID BIOSYNTHESIS
PROMOTE LIPID DROPLET FORMATION BY INCREASING GLUT1
LEVELS IN THE PLASMA MEMBRANE
L. Li1, R. Mobini1, E. Lu1, M. Rutberg1, M. Ståhlman1, L. Håversen1, B. Liu1,
T. Larsson1, R. Perkins1, L. Andersson1, K. Koistinen2, K. Ekroos2, J. Borén1,
S.-O. Olofsson1. 1Sahlgrenska Center for Cardiovascular and Metabolic
Research, Wallenberg Laboratory, University of Gothenburg, Gothenburg,
Sweden, 2Zora Biosciences Oy, Espoo, Finland
Lipid droplets are organelles involved in the storage and processing of neutral
lipids such as triglycerides, and recent evidence suggests a close interaction
between lipid droplets and specialized domains of the plasma membrane known
as lipid rafts.
Here we identified ARAP2 as a lipid droplet-associated protein that increases
the formation of lipid droplets by promoting triglyceride biosynthesis. ARAP2
increased basal glucose uptake and GLUT1 levels in the lipid raft fraction
of the plasma membrane, which likely explains the increased triglyceride
biosynthesis. We also showed that ARAP2 influenced the lipid composition
of cells and the lipid raft fraction by promoting sphingomyelin biosynthesis
and reducing glucosylceramide biosynthesis. Furthermore, we showed that
ARAP2 could mediate these effects by inhibiting the activity of glucosylceramide
synthase. Inhibition of this enzyme promoted the activity of plasma membrane
sphingomyelin synthase 2 and the accumulation of GLUT1 in the lipid raft
fraction of the plasma membrane. We also showed that palmitic acid increased
the expression of ARAP2 and GLUT1 levels in the lipid raft fraction.
Our data indicate that GLUT1 levels in lipid rafts, and hence basal glucose
uptake and triglyceride biosynthesis, can be increased by an ARAP2-induced
reduction in GCS activity and in the glucosylceramide biosynthesis. We
therefore propose that ARAP2 is part of a mechanism that protects cells from
lipotoxic fatty acids by increasing basal glucose uptake to promote lipid droplet
formation.
129 A NOVEL THREE-PROTEIN COMPLEX REGULATES IN VITRO
VTV-GOLGI FUSION
S.A. Siddiqi, E. Nafi-Valencia, S. Siddiqi, A. Rahim. Burnett School of
Biomedical Sciences, University of Central Florida, Orlando, FL, USA
Elevated concentrations of circulating plasma very low-density lipoproteins
(VLDLs) play an important role in the pathogenesis of atherosclerosis. VLDLs
are synthesized in the liver and secreted into the blood. The rate-determining
step in the secretion of VLDLs from the liver is their transport from their
site of biogenesis, the endoplasmic reticulum (ER), to the Golgi. We reported
recently that this physiologically regulatable step is mediated by a specialized
ER-derived VLDL transport vesicle (VTV). VTV fuses with hepatic cis-Golgi to
facilitate the targeted delivery of VLDL to the Golgi lumen. In vitro fusion of VTV
with hepatic cis-Golgi requires cytosol, however, cytosolic factors regulating
fusion event remain unidentified. To identify cytosolic factors, we performed a
series of chromatographic steps including FPLC on liver cytosol and isolated
a complex of three cytosolic proteins, which we found is required for in
vitro VTV-Golgi fusion. Tandem mass spectrometry coupled with N-terminal
sequencing analyses identified the proteins as hsp72, p97 and hsp27. Western
blotting data using antibodies to hsc70, p97 and hsp27 confirmed their
identity. To examine the functionality of these proteins in VTV-Golgi fusion,
we immunodepleted hepatic cytosol of hsc70, p97 and hsp27 using specific
antibodies. Immunodepletion of each of the three proteins resulted in significant
reduction in VTV-Golgi fusion. Addition of recombinant hsc70, p97 and hsp27
proteins to the immunodepleted-cytosol completely restored the fusion activity.
We conclude that hsc70, p97 and hsp27 form a complex in cytosol, which
regulates the fusion VTV with hepatic cis-Golgi and thus VLDL-delivery to the
Golgi lumen.
130 MURINE BONE MARROW-DERIVED MACROPHAGES
DIFFERENTIATED WITH GM-CSF BECOME FOAM CELLS BY PI
3-KINASE GAMMA-DEPENDENT FLUID-PHASE PINOCYTOSIS
OF NATIVE LDL
J.J. Anzinger1, J. Chang1, Q. Xu1, T. Bohnacker2, M.P. Wymann2, H.S. Kruth1.
1Experimental Atherosclerosis Section, NHLBI, NIH, Bethesda, MD, USA,
2Department of Biomedicine, Institute of Biochemistry and Genetics, University
of Basel, Basel, Switzerland
Accumulation of cholesterol by macrophage LDL uptake is a key event in the
formation of atherosclerotic plaques. Previous research has shown that GM-
CSF differentiates macrophages, is present in atherosclerotic plaques, and
promotes plaque lipid accumulation. However, it has not been determined
if murine GM-CSF-differentiated macrophages take up LDL to become
cholesterol-rich foam cells. In this study, murine bone marrow-derived cells were
differentiated into macrophages with GM-CSF. These GM-CSF differentiated
macrophages showed massive, progressive accumulation of cholesterol during
incubation with LDL. Incubation of LDL receptor-null or wild-type macrophages
with increasing concentrations of 125I-LDL showed non-saturable macrophage
LDL uptake that was linearly related to the LDL amount added, indicating
receptor-independent LDL uptake mediated by fluid-phase pinocytosis. Since
previous studies showed an important role for PI3K in atherosclerosis
development and macrophage fluid-phase pinocytosis, we investigated the role
of PI3K in mediating macrophage fluid-phase pinocytosis of LDL. Wild-type
macrophages incubated with LDL and the PI3K-gamma inhibitor AS605240
showed a ~50% reduction in LDL uptake and net cholesterol accumulation
compared with macrophages incubated with LDL only. Incubation of PI3K-
gamma-null macrophages with LDL showed a similar ~50% reduction in LDL
uptake and net cholesterol accumulation compared with wild-type macrophages
incubated only with LDL. These results show that GM-CSF-differentiated murine
macrophages become cholesterol-rich foam cells by fluid-phase pinocytosis
of native LDL and identify PI3K-gamma as contributing to this process.
PI3K-gamma-dependent macrophage foam cell formation mediated by fluid-
phase pinocytosis provides mechanistic insight for the decreased vascular lipid
accumulation previously observed during atherosclerosis development in mice
lacking PI3K-gamma.
131 LIPID DROPLETS: STRUCTURE, PROTEIN ORGANIZATION AND
BIOGENESIS
H. Robenek1, N.J. Severs2, G. Weissen-Plenz1, A. Ruebel1, I. Buers1. 1Cell
Biology and Ultrastructure Research, Leibniz-Institute for Arteriosclerosis
Research, Univ. Muenster, Münster, Germany, 2Heart and Lung Institute,
Imperial College London, London, UK
An entirely new view of lipid droplets is emerging: lipid droplets are not merely
storage depots for superfluous intracellular lipids in times of hyperlipidic stress,
but metabolically active organelles involved in cellular homeostasis. Virtually
all recent advances in our concepts on the metabolic functions of lipid droplets
have come from studies on lipid droplet-associated proteins. This realization has
made the study of proteins, such as PAT family proteins, caveolins and several
others that are targeted to lipid droplets, an intriguing and rapidly developing
area of intensive inquiry. Despite the progress in lipid droplet research,
however, the lipid droplet is still a poorly understood organelle. Our existing
understanding of the structure, protein organization and biogenesis of the lipid
droplet has relied heavily on microscopical techniques that lack resolution and
the ability to preserve native cellular and protein composition. The electron
microscopic technique, freeze-fracture replica immunogold labeling, overcomes
these disadvantages and can be used to define at high resolution the precise
location of lipid droplet-associated proteins in specific membrane systems
and organelles of the cell. In this presentation illustrative examples of how
freeze-fracture immunocytochemistry has contributed to our understanding of
the identification, spatial organization in the membrane plane as well as the
dynamic cellular processes and function of PAT family proteins and caveolin-1
are shown. By revisiting the lipid droplet and its associated proteins with
freeze-fracture immunocytochemistry, new perspectives have emerged which
challenge prevailing concepts of lipid droplet biology and may hopefully provide
a timely impulse for many ongoing studies.
132 TRIACYLGLYCEROL-RICH LIPOPROTEINS INFLUENCE ON
THE INACTIVATION OF LIPOPROTEIN LIPASE BY ANGPTL 3 AND
ANGPTL 4
S. Nilsson1, M. Larsson1, E. Worrsjö1, A. Lookene1,2, V. Suokonina1,3,
E. Makoveichuk1, J. Heeren4, G. Olivecrona1. 1Physiological Chemistry, Umeå
University, Umeå, Sweden, 2Tallinn University of Technology, Tallinn, Estonia,
3Biomedicine, University of Gothenburg, Göteborg, Sweden, 4IBMII: Molecular
Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg,
Germany
Objectives: Angiopoietin-like proteins (ANGPTL3 and -4) are present both
in tissues and in blood and have been found to modulate the activity of
LPL. We wanted to investigate if lipoproteins influence on this interaction
and if ANGPTL3 and -4 could influence LPL-dependent, receptor-mediated
endocytosis of lipoproteins by primary hepatocytes.
Methods: LPL activity was measured after pre-incubation in the presence
of ANGPTL3 or -4 with or without chylomicrons, VLDL or LDL. Binding of
ANGPTL3 and -4 to the lipoproteins was investigated by SPR and ELISA.
LPL-dependent uptake of 125I-labeled triacylglycerol-rich lipoproteins (TRLs) in
hepatocytes was investigated in the presence or absence of ANGPTL3 and -4.
Results: TRLs significantly reduced the inactivation of LPL by ANGPTL3 and -4,
while LDL had less effect on the inactivation. LPL bound to the TRLs, while
ANGPTLs did not bind. The ANGPTLs were also found to decrease LPL-
dependent uptake of 125I-labeled TRLs in primary hepatocytes.
Conclusions: Our data show that LPL is protected from inactivation by
ANGPTLs already at sub-physiological levels of TRLs, implying that circulating
ANGPTLs may have little effect on LPL at the luminal side of the endothelium.
This may explain why there is little correlation between plasma concentrations
of ANGPTLs and plasma TG levels or LPL activity in tissues. Our data
